Companies/Rejuvel Bio-Sciences, Inc.
Company profile

Rejuvel Bio-Sciences, Inc.

OTC: NUUU · Consumer Defensive · Household & Personal Products
PublicHQ Miami, FL · Miami-DadeCIK 0001481427Reports USD
#312 of 382 Consumer Defensive companies by revenuebottom-quartile growth
EA Score
Revenue TTM
$187.3k
Rev growth YoY (TTM)
+135.9%
Net income (FY)
-$244.8k
Employees
1
as of 2026-08-28
Market cap
$117.8k
as of 2026-08-28

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$70.4k$70.4k2014
Net income-$244.8k-$244.8k2014
Operating income-$211.0k-$211.0k2014
Total assets$230.1k$230.1k2014
Liabilities$1.2M$1.2M2014
Equity-$932.3k-$932.3k2014

Revenue trend

FY2011 – FY2014 · USD
FY11
FY12
FY13
FY14
FY14
FY14

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Rejuvel Bio-Sciences, Inc.’s revenue?

Rejuvel Bio-Sciences, Inc. booked $70.4k in FY2014 revenue, contracting 25% year over yearslower than 84% of Consumer Defensive companies we track, at a -348.0% net margin.

Key facts
CEOCharles J. Scimeca
SectorConsumer Defensive
IndustryHousehold & Personal Products
HeadquartersMiami, FL
ExchangeOTC: NUUU
Employees1
IPO date2014-04-23
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.